478 related articles for article (PubMed ID: 26159261)
1. How to Diagnose and Exclude Drug-Induced Liver Injury.
Watkins PB
Dig Dis; 2015; 33(4):472-6. PubMed ID: 26159261
[TBL] [Abstract][Full Text] [Related]
2. Causality assessment for suspected DILI during clinical phases of drug development.
Regev A; Seeff LB; Merz M; Ormarsdottir S; Aithal GP; Gallivan J; Watkins PB
Drug Saf; 2014 Nov; 37 Suppl 1(Suppl 1):S47-56. PubMed ID: 25352327
[TBL] [Abstract][Full Text] [Related]
3. [Clinical and pathological features in 138 cases of drug-induced liver injury].
Lai RT; Wang H; Gui HL; Ye MZ; Dai WJ; Xiang XG; Zhao GD; Wang WJ; Xie Q
Zhonghua Gan Zang Bing Za Zhi; 2012 Mar; 20(3):185-9. PubMed ID: 22475136
[TBL] [Abstract][Full Text] [Related]
4. Top-ranking drugs out of 3312 drug-induced liver injury cases evaluated by the Roussel Uclaf Causality Assessment Method.
Teschke R
Expert Opin Drug Metab Toxicol; 2018 Nov; 14(11):1169-1187. PubMed ID: 30354694
[TBL] [Abstract][Full Text] [Related]
5. Drug Induced Liver Injury: Can Biomarkers Assist RUCAM in Causality Assessment?
Teschke R; Schulze J; Eickhoff A; Danan G
Int J Mol Sci; 2017 Apr; 18(4):. PubMed ID: 28398242
[TBL] [Abstract][Full Text] [Related]
6. A detection algorithm for drug-induced liver injury in medical information databases using the Japanese diagnostic scale and its comparison with the Council for International Organizations of Medical Sciences/the Roussel Uclaf Causality Assessment Method scale.
Hanatani T; Sai K; Tohkin M; Segawa K; Kimura M; Hori K; Kawakami J; Saito Y
Pharmacoepidemiol Drug Saf; 2014 Sep; 23(9):984-8. PubMed ID: 24596340
[TBL] [Abstract][Full Text] [Related]
7. Role of liver biopsy in the era of clinical prediction scores for "drug-induced liver injury" (DILI): experience of a tertiary referral hospital.
Costa-Moreira P; Gaspar R; Pereira P; Lopes S; Canão P; Lopes J; Carneiro F; Macedo G
Virchows Arch; 2020 Oct; 477(4):517-525. PubMed ID: 32377873
[TBL] [Abstract][Full Text] [Related]
8. Clinical features, diagnosis, and natural history of drug-induced liver injury.
Hayashi PH; Fontana RJ
Semin Liver Dis; 2014 May; 34(2):134-44. PubMed ID: 24879979
[TBL] [Abstract][Full Text] [Related]
9. Characteristic molecular and proteomic signatures of drug-induced liver injury in a rat model.
Eun JW; Bae HJ; Shen Q; Park SJ; Kim HS; Shin WC; Yang HD; Jin CY; You JS; Kang HJ; Kim H; Ahn YM; Park WS; Lee JY; Nam SW
J Appl Toxicol; 2015 Feb; 35(2):152-64. PubMed ID: 25231249
[TBL] [Abstract][Full Text] [Related]
10. The Liver Toxicity Knowledge Base (LKTB) and drug-induced liver injury (DILI) classification for assessment of human liver injury.
Thakkar S; Chen M; Fang H; Liu Z; Roberts R; Tong W
Expert Rev Gastroenterol Hepatol; 2018 Jan; 12(1):31-38. PubMed ID: 28931315
[TBL] [Abstract][Full Text] [Related]
11. Liver Injury in COVID-19 Patients with Drugs as Causatives: A Systematic Review of 996 DILI Cases Published 2020/2021 Based on RUCAM as Causality Assessment Method.
Teschke R; Méndez-Sánchez N; Eickhoff A
Int J Mol Sci; 2022 Apr; 23(9):. PubMed ID: 35563242
[TBL] [Abstract][Full Text] [Related]
12. Hepatotoxicity by Drugs: The Most Common Implicated Agents.
Björnsson ES
Int J Mol Sci; 2016 Feb; 17(2):224. PubMed ID: 26861310
[TBL] [Abstract][Full Text] [Related]
13. Assessment of drug-induced liver injury in clinical practice.
Lucena MI; García-Cortés M; Cueto R; Lopez-Duran J; Andrade RJ
Fundam Clin Pharmacol; 2008 Apr; 22(2):141-58. PubMed ID: 18353109
[TBL] [Abstract][Full Text] [Related]
14. Utility of a Computerized ICD-10 Algorithm to Identify Idiosyncratic Drug-Induced Liver Injury Cases in the Electronic Medical Record.
Yeboah-Korang A; Louissaint J; Tsung I; Prabhu S; Fontana RJ
Drug Saf; 2020 Apr; 43(4):371-377. PubMed ID: 31916081
[TBL] [Abstract][Full Text] [Related]
15. Causality assessment in drug-induced liver injury.
Hayashi PH
Semin Liver Dis; 2009 Nov; 29(4):348-56. PubMed ID: 19826968
[TBL] [Abstract][Full Text] [Related]
16. Incidence and Etiology of Drug-Induced Liver Injury in Mainland China.
Shen T; Liu Y; Shang J; Xie Q; Li J; Yan M; Xu J; Niu J; Liu J; Watkins PB; Aithal GP; Andrade RJ; Dou X; Yao L; Lv F; Wang Q; Li Y; Zhou X; Zhang Y; Zong P; Wan B; Zou Z; Yang D; Nie Y; Li D; Wang Y; Han X; Zhuang H; Mao Y; Chen C
Gastroenterology; 2019 Jun; 156(8):2230-2241.e11. PubMed ID: 30742832
[TBL] [Abstract][Full Text] [Related]
17. Drug properties and host factors contribute to biochemical presentation of drug-induced liver injury: a prediction model from a machine learning approach.
Gonzalez-Jimenez A; Suzuki A; Chen M; Ashby K; Alvarez-Alvarez I; Andrade RJ; Lucena MI
Arch Toxicol; 2021 May; 95(5):1793-1803. PubMed ID: 33666709
[TBL] [Abstract][Full Text] [Related]
18. [Current status of Chinese herbal preparations included in LiverTox database].
Jin R; Gu HY; Li LL; Sun LL
Zhonghua Gan Zang Bing Za Zhi; 2016 Nov; 24(11):817-823. PubMed ID: 27978926
[No Abstract] [Full Text] [Related]
19. Drug-Induced Liver Injury: Why is the Roussel Uclaf Causality Assessment Method (RUCAM) Still Used 25 Years After Its Launch?
Danan G; Teschke R
Drug Saf; 2018 Aug; 41(8):735-743. PubMed ID: 29502198
[TBL] [Abstract][Full Text] [Related]
20. A revised electronic version of RUCAM for the diagnosis of DILI.
Hayashi PH; Lucena MI; Fontana RJ; Bjornsson ES; Aithal GP; Barnhart H; Gonzalez-Jimenez A; Yang Q; Gu J; Andrade RJ; Hoofnagle JH
Hepatology; 2022 Jul; 76(1):18-31. PubMed ID: 35014066
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
